FundingWatcher
Home / Investors / Biotech investors / Biotech investors in China

Biotech investors in China

Updated 16 Nov 2026

Reset

Venture funds

28 funds, by portfolio companies funded in the last 12 months
#FundSectorsStages LeadsFunded, 12 months
1 Qiming Venture Partners
Qiming Venture Partners invests in technology, consumer and healthcare companies at early and growth stages, with recent investments including Houmo.AI and AusperBio.
Shanghai, China
Health care, Artificial intelligence Seed, Early stage venture, Late stage venture 50% 11
2 Legend Capital
Legend Capital invests in China, with recent investments including Infinigence and Sinsegye.
Beijing, China
Artificial intelligence, Hardware Seed, Early stage venture, Late stage venture 42% 7
3 BioVenture
BioVenture offers early and growth stage investment, with recent investments including AusperBio and Degron Therapeutics.
Suzhou, China
Health care, Biotech Seed, Early stage venture, Late stage venture 33% 4
4 K2VC
K2VC invests in early stage technology startups, including Shexu Technology and Startorus Fusion.
Beijing, China
Commerce, Fintech Seed, Early stage venture 22% 4
5 Gaorong Capital
Gaorong Capital focuses on TMT investments including AI and frontier technologies, including BioGeometry and Raysolve.
Wangjing, China
Artificial intelligence, Hardware Seed, Early stage venture, Late stage venture 29% 3
6 Haitang Fund
Haitang Fund is a venture fund founded by Tianjin University alumni entrepreneurs, with recent investments in Zhonghe Gene and Xingsai Bio.
Nankai, China
Biotech, Health care Early stage venture 30% 3
7 IDG Capital
IDG Capital funds early- to growth-stage technology companies, with recent investments including Zero Zero Robotics and XPENG Robotics.
Beijing, China
Hardware, Fintech Seed, Early stage venture, Late stage venture 36% 3
8 Matrix Partners China
Matrix Partners China builds long-term relationships with entrepreneurs in China, with recent investments including Houmo.AI and Astribot.
Beijing, China
Artificial intelligence, Hardware Early stage venture 34% 3
9 Med-Fine Capital
Med-Fine Capital focuses on healthcare and bio-science, with recent investments including Artivila Therapeutics and Phrontline Biopharma.
Shanghai, China
Health care, Biotech Early stage venture 30% 3
10 Shenzhen Capital Group
Shenzhen Capital Group focuses on cultivating national industries and national brands, with recent investments including SAGE Intelligent and Chasing Innovation.
Nanshan, China
Hardware, Health care Seed, Early stage venture, Late stage venture 40% 3
11 Shunwei Capital
Shunwei Capital focuses on China's internet industry at early to mid stages, with recent companies including SAGE Intelligent and Hooke Instruments.
Beijing, China
Hardware, Commerce Seed, Early stage venture, Late stage venture 31% 3
12 BioTrack Capital
BioTrack Capital invests in life sciences, healthcare technology and biotechnology, with recent companies including Yuce Biotechnology and Rigen Biotech.
Shanghai, China
Health care, Biotech Seed, Early stage venture, Late stage venture 33% 2
13 Boyuan Capital
Boyuan Capital operates as an investment platform, with recent companies Yuce Biotechnology and Rigen Biotech.
Shanghai, China
Health care, Biotech Late stage venture 38% 2
14 Chengdu Science and Technology Venture Capital
Chengdu Science and Technology Venture Capital is a venture firm with recent companies including Kunteng Tech, QL Biopharma and New Radiomedicine Technology.
Chengdu, China
Biotech, Health care Early stage venture, Late stage venture 36% 2
15 Fuho Capital
Fuho Capital is an equity investment fund management company with recent investments in Novamab and Leman Biotech.
Haidian, China
Biotech, Health care Seed, Early stage venture, Late stage venture 24% 2
16 Green Pine Capital Partners
Green Pine Capital Partners is a venture firm whose recent companies include RealAI and MindRank AI.
Shenzhen, China
Hardware, Artificial intelligence Seed, Early stage venture, Late stage venture 32% 2
17 Kaitai Capital
Kaitai Capital is a professional investment management organization, with recent companies including Xihu Xinchen and Bivision.
Hangzhou, China
Artificial intelligence, Biotech Early stage venture 30% 2
18 Lenovo Capital and Incubator Group (LCIG)
Lenovo Capital and Incubator Group operates as an accelerator and venture firm, with recent investments including Elite Robots and Aibo Medical Robot.
Beijing, China
Hardware, Artificial intelligence Seed, Early stage venture, Late stage venture 24% 2
19 Linear Capital
Linear Capital invests in data application projects, with recent companies SynMetaBio, Dishi Medical and ReaVis.
Shanghai, China
Artificial intelligence, Hardware Seed, Early stage venture, Late stage venture 31% 2
20 5Y Capital
5Y Capital makes early-stage venture investments, with recent investments in Etern and CellCentric.
Xuhui, China
Artificial intelligence, Commerce Seed, Early stage venture, Late stage venture 31% 2
21 Northern Light Venture Capital
Northern Light Venture Capital funds early- and growth-stage tech and consumer service companies, with recent investments including HemaCell and Picky.
Beijing, China
Hardware, Artificial intelligence Seed, Early stage venture, Late stage venture 24% 2
22 Oriza Holdings
Oriza Holdings provides equity and debt financing to Chinese companies, with recent backings including Listenai and TuringQ.
Suzhou, China
Hardware, Artificial intelligence Seed, Early stage venture, Late stage venture 25% 2
23 SDIC Venture Capital
SDIC Venture Capital manages four funds for semiconductor and pharmaceutical companies, including Bangxin Semiconductor and Ouye Semiconductor.
Xicheng, China
Hardware, Health care Seed, Early stage venture, Late stage venture 54% 2
24 Sherpa Healthcare Partners
Sherpa Healthcare Partners focuses on pharmaceutical and biotech companies, with recent investments in MindRank AI and UniXell Biotechnology.
Beijing, China
Health care, Biotech Seed, Early stage venture, Late stage venture 29% 2
25 SZHTI Group
SZHTI Group provides asset management and financing services, including investments tied to Elegoo and SpinQ Technology.
Shenzhen, China
Hardware, Biotech Early stage venture 30% 2
26 Tiantu Capital
Tiantu Capital is a venture capital association, with recent investments in Xellar Biosystems and Leman Biotech.
Shenzhen, China
Commerce, Artificial intelligence Seed, Early stage venture 52% 2
27 Wuxi Capital
Wuxi Capital is a financial investment platform backing companies such as Kai Medtech and Sandstone.
Wuxi Shi, China
Hardware, Health care Seed 34% 2
28 Zhengxuan Investment
Zhengxuan Investment invests in high-tech enterprises, with recent companies Yuce Biotechnology and Xellar Biosystems.
Shenzhen, China
Hardware, Artificial intelligence Seed, Early stage venture 49% 2

Table 1. Biotech investors in China: venture capital and micro VC funds ranked by biotech companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.

Biotech investors in China
One-time CSV
  • 124 firms, 120 with a website
  • 86 firm email addresses
  • 91 phone numbers
  • CRM-ready CSV, 15 columns
  • Download right after payment
With partner contacts
Compiled to order
  • The full list, plus the people who invest
  • Up to 2 partners per firm, compiled to order
  • Name, job title and LinkedIn where found
  • Verified direct email per person
  • List CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

investors-sector-biotech-china-500a.csv124 rows × 15 columns
InvestorTypeLocationEmailPhone
Qiming Venture PartnersVenture capital firmShanghai, China•••@qimingvc.com(+86) •••
Legend CapitalVenture capital firmBeijing, China•••@legendcapital.com.cn
Lilly Asia VenturesVenture capital firmShanghai, China•••@lillyasiaventures.com+86 21•••
Matrix Partners ChinaVenture capital firmBeijing, China•••@matrixpartners.com.cn+86-10•••
BioVentureVenture capital firmSuzhou, China•••@bioventure.com.cn+86512•••
Shenzhen Capital GroupVenture capital firmNanshan, China•••@szvc.com.cn0755-8•••
Northern Light Venture CapitalVenture capital firmBeijing, China•••@nlightvc.com650-58•••
IDG CapitalPrivate equity firmBeijing, China•••@idgcapital.com+86 10•••

8 rows of the CSV in 5 of its 15 columns, email and phone masked.

124
Investors
86
With email
91
With phone
112
Active in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Biotech investors in China

30 of 124, most investments first
30 rows
# Investor Type Location Invests in Latest portfolio companies Funded, 12 months Investments Lead Exits Email Phone LinkedIn
1 Qiming Venture Partners Venture capital firm Shanghai, China Health care, Artificial intelligence Houmo.AI, Infinigence, AusperBio 21 1,106 555 104 •••@qimingvc.com (+86) ••• In the CSV
2 Legend Capital Venture capital firm Beijing, China Artificial intelligence, Hardware Infinigence, Sinsegye, Diyingjia Technology 18 569 240 60 •••@legendcapital.com.cn In the CSV
3 Lilly Asia Ventures Venture capital firm Shanghai, China Health care, Biotech Precede Biosciences, Akura Medical 2 237 68 49 •••@lillyasiaventures.com +86 21••• In the CSV
4 Matrix Partners China Venture capital firm Beijing, China Artificial intelligence, Hardware Houmo.AI, Astribot, SemiDrive 14 793 271 59 •••@matrixpartners.com.cn +86-10••• In the CSV
5 BioVenture Venture capital firm Suzhou, China Health care, Biotech AusperBio, Degron Therapeutics, AccuPulse 5 182 60 13 •••@bioventure.com.cn +86512•••
6 Kaitai Capital Venture capital firm Hangzhou, China Artificial intelligence, Biotech Xihu Xinchen, Bivision, Levinthal 3 149 44 8 +86 57••• In the CSV
7 Shenzhen Capital Group Venture capital firm Nanshan, China Hardware, Health care SAGE Intelligent, Chasing Innovation, Kai Medtech 16 794 316 102 •••@szvc.com.cn 0755-8••• In the CSV
8 Northern Light Venture Capital Venture capital firm Beijing, China Hardware, Artificial intelligence Nutshell Therapeutics, HemaCell, Picky 5 458 110 66 •••@nlightvc.com 650-58••• In the CSV
9 Gaorong Capital Venture capital firm Wangjing, China Artificial intelligence, Hardware BioGeometry, Shexu Technology, Raysolve 9 358 103 29 010-84••• In the CSV
10 IDG Capital Private equity firm, Venture capital firm Beijing, China Hardware, Fintech Zero Zero Robotics, XPENG Robotics, LaiHua 13 1,565 567 183 •••@idgcapital.com +86 10••• In the CSV
11 K2VC Angel group, Venture capital firm Beijing, China Commerce, Fintech Renshuo Solar, Shexu Technology, Aureka Biotechnologies 9 337 73 9 •••@k2vc.com +86 10••• In the CSV
12 Puhua Capital Venture capital firm Hangzhou, China Hardware, Health care Yuce Biotechnology, LaiHua, Garen Semiconductor 6 269 88 14 •••@puhuacapital.com +571 8••• In the CSV
13 5Y Capital Venture capital firm Xuhui, China Artificial intelligence, Commerce Etern, CellCentric, BOTINKIT 4 345 108 28 +86 20••• In the CSV
14 Frees Fund Venture capital firm Beijing, China Artificial intelligence, Hardware Vibronix, Aeroband, Calterah 5 233 63 12 •••@freesvc.com In the CSV
15 BioTrack Capital Venture capital firm Shanghai, China Health care, Biotech Yuce Biotechnology, Shenluo Medical, Rigen Biotech 3 85 28 5 +86-02•••
16 Prox Ventures Venture capital firm Shanghai, China Biotech, Health care Leadinno Medical Valley 1 71 14 1 In the CSV
17 Shunwei Capital Venture capital firm Beijing, China Hardware, Commerce SAGE Intelligent, Hooke Instruments, Zongwei Automation 12 607 188 46 •••@shunwei.com +86 (0••• In the CSV
18 Fortune Venture Capital Venture capital firm Shenzhen, China Hardware, Artificial intelligence Global Technology, Zhongke Ruijian, Xunjie Guangyuan 15 366 140 47 •••@fortunevc.com In the CSV
19 Source Code Capital Venture capital firm Chaoyang, China Artificial intelligence, Hardware FAIRINO, Nutshell Therapeutics, Raysolve 10 356 113 19 +86106••• In the CSV
20 Addor Capital Venture capital firm Nanjing, China Hardware, Artificial intelligence Zhizhen Precision, Micronano Core, Layerwave Bio 8 350 173 26 •••@addorcapital.com 025-85••• In the CSV
21 Oriental Fortune Capital Venture capital firm Shenzhen, China Hardware, Artificial intelligence Micronano Core, Renshuo Solar, EVAS Intelligence 9 342 117 32 •••@ofcapital.com +86-75••• In the CSV
22 CICC Investment bank, Venture capital firm Beijing, China Hardware, Artificial intelligence Global Technology, AIForceTech, Etern 9 239 95 58 •••@cicc.com.cn (+86-1••• In the CSV
23 Oriza Holdings Venture capital firm Suzhou, China Hardware, Artificial intelligence Mogulinker Technology, Muchuang, Listenai 7 220 56 22 •••@oriza.com.cn In the CSV
24 SDIC Venture Capital Venture capital firm Xicheng, China Hardware, Health care Bangxin Semiconductor, Shengqiang Technology, Weikaier Pharmaceutical Technology 9 164 89 12 •••@sdicvc.com 010-63••• In the CSV
25 Yinxinggu Capital Venture capital firm Hangzhou, China Hardware, Artificial intelligence Chasing Innovation, Lingshu Intelligent Technology, Mogulinker Technology 8 161 18 7 •••@yxgzb.com + 0571••• In the CSV
26 Huagai Capital Private equity firm Beijing, China Hardware, Biotech Utarn Technology, Bluesail Surgical, MindRank AI 4 148 59 17 •••@hgcapital.cn +8610-••• In the CSV
27 Sherpa Healthcare Partners Venture capital firm Beijing, China Health care, Biotech MindRank AI, UniXell Biotechnology 2 99 29 10 •••@sherpahp.com 010 - ••• In the CSV
28 New Alliance Capital Private equity firm, Venture capital firm Shanghai, China Health care, Biotech Degron Therapeutics 1 96 9 10 •••@nac-capital.com 86-21-••• In the CSV
29 Haiyuan Capital Venture capital firm Shenzhen, China Health care, Biotech Hongxin Biology 1 70 40 3
30 3E Bioventures Venture capital firm Beijing, China Biotech, Health care Tianhu Technology 1 62 21 10 (810) ••• In the CSV

Table 2. Biotech investors in China: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 124.

Most active in the last 12 months

By portfolio companies funded
#InvestorLocation Funded, 12 monthsPortfolioLatest
1 Lenovo Capital and Incubator Group (LCIG) Beijing, China 27 99 Micronano Core, Elite Robots, Aibo Medical Robot
2 Qiming Venture Partners Shanghai, China 21 154 Houmo.AI, Infinigence, AusperBio
3 Legend Capital Beijing, China 18 103 Infinigence, Sinsegye, Diyingjia Technology
4 CAS Star Xian, China 17 58 Matrixtime Robotics, Renshuo Solar, YUSUR Technology
5 Shenzhen Capital Group Nanshan, China 16 166 SAGE Intelligent, Chasing Innovation, Kai Medtech
6 Fortune Venture Capital Shenzhen, China 15 79 Global Technology, Zhongke Ruijian, Xunjie Guangyuan
7 Matrix Partners China Beijing, China 14 186 Houmo.AI, Astribot, SemiDrive
8 IDG Capital Beijing, China 13 257 Zero Zero Robotics, XPENG Robotics, LaiHua
9 Shunwei Capital Beijing, China 12 125 SAGE Intelligent, Hooke Instruments, Zongwei Automation
10 TusStar Beijing, China 11 33 Zhizhen Precision, Wuwen Zhike, Qianjue Technology
11 Source Code Capital Chaoyang, China 10 98 FAIRINO, Nutshell Therapeutics, Raysolve
12 Baidu Ventures Beijing, China 10 45 Nutshell Therapeutics, Xihu Xinchen, RealAI
13 SDIC Venture Capital Xicheng, China 9 36 Bangxin Semiconductor, Shengqiang Technology, Weikaier Pharmaceutical Technology
14 CICC Beijing, China 9 53 Global Technology, AIForceTech, Etern
15 Oriental Fortune Capital Shenzhen, China 9 93 Micronano Core, Renshuo Solar, EVAS Intelligence

Table 3. Biotech investors in China: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Latest rounds in their portfolios

Newest first
10 rows
Company What they do Sector Location Last round Amount Date Total raised Investors on this list Employees Founded
Huasaiboman Medical Cell Biology Huasaiboman Medical Cell Biology provides new cell therapy technologies and solutions as a biotechnology company. Biotech Qingdao Shi, China Series B $30.0M 2026-11-09 $30.0M ASBV 11 to 50 2019
Tushen Zhihe Tushen Zhihe provides artificial intelligence protein design services. Artificial intelligence Minhang, China Seed $1.4M 2026-11-09 $1.5M Wuxi Capital 11 to 50 2023
Bangxin Semiconductor Bangxin Semiconductor delivers cost-effective semiconductor equipment. Hardware Shanghai, China Series B $90.0M 2026-11-05 $90.0M SDIC Venture Capital 2020
Moffett AI Moffett AI designs AI chips and provides terminal and cloud AI chip acceleration solutions. Artificial intelligence Los Altos, United States Series C $150.0M 2026-11-03 $322.8M ZhenFund, Qianhai Fund of Funds 11 to 50 2018
Global Technology Global Technology supplies automotive intelligent driving systems. Hardware Mumbai, India Series C $90.0M 2026-11-03 $153.9M CICC, Fortune Venture Capital 101 to 250 2001
Zhongke Ruijian Zhongke Ruijian provides an AI-based counterfeit detection platform for digital content security. Artificial intelligence Hangzhou, China Series A $14.0M 2026-11-03 $14.0M Fortune Venture Capital 11 to 50 2020
Enjosim Enjosim researches, manufactures, and sells self-delivery systems for biomacromolecule pharmaceuticals. Biotech Shanghai, China Series B $30.1M 2026-11-02 $30.1M Luminous Ventures (former Lightspeed China Partners) 51 to 100 2021
Micronano Core Micronano Core develops and researches AIoT chip products for intelligent IoT and advanced technology applications. Artificial intelligence Hangzhou, China Series C $150.0M 2026-10-28 $490.5M Lenovo Capital and Incubator Group (LCIG), Addor Capital, Oriental Fortune Capital 11 to 50 2021
Elite Robots Elite Robots manufactures automated machinery and provides robotics solutions for industrial production. Hardware Shanghai, China Series D $30.0M 2026-10-28 $153.8M Lenovo Capital and Incubator Group (LCIG) 101 to 250 2016
Chasing Innovation Chasing Innovation develops and manufactures submersible drone products and solutions. Hardware Shenzhen, China Series C $15.0M 2026-10-28 $47.8M Shenzhen Capital Group, Yinxinggu Capital, Qianhai Fund of Funds 51 to 100 2016

Table 4. Biotech investors in China: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.

Portfolio sectors

Portfolio sectorsCompaniesShare
Software 1,746 66%
Hardware 686 26%
Artificial intelligence 534 20%
Health care 416 16%
Fintech 270 10%
Biotech 243 9%
Commerce 226 9%
Education 162 6%
Energy 68 3%
Cybersecurity 64 2%

Table 5. Biotech investors in China: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Investment stages

Table 6. Biotech investors in China by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesInvestorsShare
Beijing 42 34%
Shanghai 24 19%
Shenzhen 18 15%
Hangzhou 5 4%
Suzhou 4 3%
Haidian 3 2%
Guangzhou 3 2%
Chengdu 3 2%
Xuhui 2 2%
Chaoyang 2 2%
Nanjing 2 2%
Xian 2 2%

Table 7. Biotech investors in China by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Founded

FoundedInvestorsShare
2020s 8 7%
2010s 64 56%
2000s 30 26%
1990s 11 10%
1970s 1 1%

Table 8. Biotech investors in China by founding decade. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech investors in China are on the list?
124, in the file dated 16 November 2026. 112 of them invested in a company whose most recent round falls in the last 12 months.
How many have an email address?
86 of the 124 carry an email address in the download and 91 a phone number.
What does the CSV contain?
One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
How much does the list cost?
$29 one-time for all 124 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV with 124 rows, 86 firm email addresses and 91 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 50 of the 86 are inboxes such as info@ or contact@. No partner names.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech investors in China: 124 rows, CSV, $29 one-time.

At once: the CSV with 124 rows, 86 firm email addresses and 91 phone numbers, on the page after payment and by mail.

The emails are the address a firm publishes: 50 of the 86 are inboxes such as info@ or contact@. No partner names.

Columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.

With partner contacts: $199 one-time. List CSV right after payment; up to 2 verified partner emails per firm compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech investors by city in China

Investor types in China

Other portfolio sectors in China

Biotech investors elsewhere

Biotech startups

Cite: FundingWatcher, 124 biotech investors in China, 16 November 2026. https://fundingwatcher.com/investors/sector/biotech/china-500a/